This book contains monographs on drugs which have been evaluated on the basis of available scientific data by consultants and members of the A. M. A. Council on Drugs. It begins with a statement of the principles governing the evaluation of the drugs which are described. The 1959 edition includes new Council monographs that have appeared in The Journal since the 1958 edition. Monographs on drugs which either have been included in the book for 20 years or are no longer commercially available have been deleted. The current edition contains approximately 500 monographs, of which 42 are new. A generic listing of available preparations and their strengths and sizes is given with each monograph. Trade names are listed at the end of each monograph and also in the index. Among the important new monographs are those for anileridine hydrochloride, dextro propoxyphene hydrochloride, iproniazid phosphate, oleandomycin phosphate, prochlorperazine, and ristocetin. In
New and Nonofficial Drugs: Containing Descriptions of Therapeutic, Prophylactic and Diagnostic Agents Evaluated by the Council on Drugs of the American Medical Association, 1959. JAMA. 1959;169(14):1686. doi:10.1001/jama.1959.03000310138029
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: